Aquestive Therapeutics (AQST) Loans - Loss Allowance (2017 - 2021)
Aquestive Therapeutics (AQST) posted quarterly Loans - Loss Allowance of $40000.0 for Q1 2021, down 52.38% year-over-year from $84000.0 in Q1 2020, and little changed quarter-over-quarter from $40000.0 in Q4 2020.
Aquestive Therapeutics (AQST) Loans - Loss Allowance (2017 - 2021) Analysis & Trends
Aquestive Therapeutics' Loans - Loss Allowance history runs 5 years deep, the most recent figure standing at $40000.0 for Q1 2021.
- In Q1 2021, Loans - Loss Allowance fell 52.38% year-over-year to $40000.0; the TTM figure through Mar 2021 stood at $40000.0 (down 52.38% YoY), while the FY2020 annual figure was $40000.0, down 67.74% from the prior year.
- Loans - Loss Allowance for Q1 2021 stood at $40000.0, roughly flat from $40000.0 in the prior quarter.
- The five-year high for Loans - Loss Allowance was $264000.0 in Q3 2020, with the low at $40000.0 in Q4 2020.
- The 5-year median for Loans - Loss Allowance is $64000.0 (2019), against an average of $88636.4.
- Peak annual rise in Loans - Loss Allowance reached 180.85% in 2020, while the deepest fall reached 67.74% in 2020.
- Aquestive Therapeutics' Loans - Loss Allowance stood at $55000.0 in 2017, then advanced by 5.45% to $58000.0 in 2018, then surged by 113.79% to $124000.0 in 2019, then tumbled by 67.74% to $40000.0 in 2020, then changed by 0.0% to $40000.0 in 2021.
- Business Quant data shows AQST's Loans - Loss Allowance at $40000.0 in Q1 2021, $40000.0 in Q4 2020, and $264000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Loss Allowance (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aquestive Therapeutics | 554.35 Mn | 554.35 Mn | 9.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 40,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | 264,000.00 |
| Jun 30, 2020 | 64,000.00 |
| Mar 31, 2020 | 84,000.00 |
| Dec 31, 2019 | 124,000.00 |
| Sep 30, 2019 | 94,000.00 |
| Jun 30, 2019 | 88,000.00 |
| Mar 31, 2019 | 64,000.00 |
| Dec 31, 2018 | 58,000.00 |
| Dec 31, 2017 | 55,000.00 |